Yahoo Web Search

Search results

1. • Does not incorporate Haleon’s business in America

     • The products, designed for people who want to quit smoking, are sold in 30 markets around the world. The sale does not incorporate Haleon’s business in America.
     Reference:

     Haleon sells nicotine replacement therapy business outside of ...

2. People also ask

   Will haleon sell its business in America?

   • The sale does not incorporate Haleon’s business in America. Haleon – which was spun off from drug giant GSK in 2022 – said the nicotine replacement therapy business generated net revenues of £217 million over 2023. Selling it will knock about 0.5% off total revenues and 1% off profits this year, it estimated.

   Haleon sells nicotine replacement therapy business outside of US for £5…

   www.standard.co.uk/business/business-news/haleon-sells-nicotine-replacement-therapy-business-outside-of-us-for-ps500m-b1166984.html

   See all results for this question

   Will haleon sell its nicotine replacement brands outside the US?

   • Sensodyne and Panadol maker Haleon has agreed to sell its nicotine replacement brands outside of the US for £500 million, as part of ongoing efforts to trim down its consumer health portfolio. The healthcare giant said it was selling its nicotine replacement therapy business to a division of Indian drugmaker Dr Reddy’s Laboratories.

   Haleon sells nicotine replacement therapy business outside of US for £5…

   www.standard.co.uk/business/business-news/haleon-sells-nicotine-replacement-therapy-business-outside-of-us-for-ps500m-b1166984.html

   See all results for this question

   Is haleon selling its nicotine replacement therapy business to Dr Reddy's Laboratories?

   • The healthcare giant said it was selling its nicotine replacement therapy business to a division of Indian drugmaker Dr Reddy’s Laboratories. Sensodyne and Panadol maker Haleon has agreed to sell its nicotine replacement brands outside of the US for £500 million, as part of ongoing efforts to trim down its consumer health portfolio.

   Haleon sells nicotine replacement therapy business outside of US for £5…

   www.standard.co.uk/business/business-news/haleon-sells-nicotine-replacement-therapy-business-outside-of-us-for-ps500m-b1166984.html

   See all results for this question

   Is Haleon a good company?

   • According to Sir Dave Lewis, Chair of Haleon, the company is an impressive business with a clear strategy to drive sustainable above-market growth and attractive shareholder returns. With a strong purpose of delivering better everyday health with humanity at its core, Haleon is primed and ready for the next stage of its remarkable journey.

   Annual Report 2022 - Haleon

   www.haleon.com/investors/annual-report-2022

   See all results for this question

   What brands does haleon own?

   • Haleon has a world-class portfolio of brands including Advil, Centrum, Sensodyne, Robitussin, and TUMS and will continue to develop category leading brands that address real consumer health needs, while focusing on future innovation across its entire portfolio.

   Haleon launches with purpose to deliver better everyday health with

   www.prnewswire.com/news-releases/haleon-launches-with-purpose-to-deliver-better-everyday-health-with-humanity-301587865.html

   See all results for this question

   How much money does haleon make a year?

   • The business, which includes the Nicotinell brand of nicotine gum, lozenges and patches, generated revenue of 217 million pounds last year. Haleon, the maker of Sensodyne toothpaste, was created by a merger of GSK (GSK.L) and Pfizer's (PFE.N) consumer healthcare businesses in 2019 and spun off from GSK in 2022.

   Haleon to sell nicotine replacement therapy business outside US for

   www.reuters.com/business/healthcare-pharmaceuticals/haleon-sell-nicotine-replacement-therapy-business-outside-us-633-mln-2024-06-26/

   See all results for this question

3. www.ft.com › content › 498a14ce-708a-4f7c-95df-300cHaleon to sell non-US nicotine replacement business for £500mn

   www.ft.com › content › 498a14ce-708a-4f7c-95df-300c

   Jun 26, 2024 · Haleon has agreed to sell its nicotine replacement therapy business outside the US for £500mn, the latest in a string of disposals of its slower-growth brands since the consumer health group...

4. www.standard.co.uk › business › business-newsHaleon sells nicotine replacement therapy business outside of ...

   www.standard.co.uk › business › business-news

   • Cached

   Jun 26, 2024 · Sensodyne and Panadol maker Haleon has agreed to sell its nicotine replacement brands outside of the US for £500 million, as part of ongoing efforts to trim down its consumer health portfolio.

   • Author: Anna Wise

5. www.reuters.com › business › healthcareHaleon to sell nicotine replacement therapy business outside ...

   www.reuters.com › business › healthcare

   Jun 26, 2024 · Haleon will sell its nicotine replacement therapy business outside the U.S. to a unit of India's Dr. Reddy's for 500 million pounds ($632.55 million), the British consumer healthcare...

6. Videos

   • 

     2:43

     youtube.com

     We expected volatility in the early days of trading, says Haleon CEO Brian McNamara

     20 Jul 2022

     5.1K views

   • 

     1:50

     facebook.com

     Haleon is 100% focused on... - New York Stock Exchange

     20 Jul 2022

     573 views

   • 

     3:25

     news.sky.com

     London's largest listing for a decade sees Haleon demerged from GSK | Business News | Sky News

     18 Jul 2022

   View all

7. www.esmmagazine.com › a-brands › haleon-to-sellHaleon To Sell Nicotine Replacement Therapy Business Outside US

   www.esmmagazine.com › a-brands › haleon-to-sell

   • Cached

   Jun 26, 2024 · Haleon plans to sell its nicotine replacement therapy business outside the US to a unit of India's Dr. Reddy's for £500 million (€592.23 million), the British consumer healthcare company has said.

8. www.marketscreener.com › quote › stockHaleon : Divestment of the nicotine replacement therapy ...

   www.marketscreener.com › quote › stock

   • Cached

   Sep 30, 2024 · On 26 June 2024, Haleon announced that it had entered into an agreement to sell its NRT business outside of the US to Dr. Reddy's Laboratories SA ("Dr. Reddy's"), a wholly owned subsidiary of Dr. Reddy's Laboratories Limited for total consideration of up to £500m (with additional proceeds from the transfer of inventory), which comprises an ...

9. www.marketscreener.com › quote › stockHaleon Closes Sale of Nicotine Replacement Therapy Business ...

   www.marketscreener.com › quote › stock

   • Cached

   Sep 30, 2024 · Haleon Closes Sale of Nicotine Replacement Therapy Business Outside US. -- Haleon said Monday it completed the divestment of its nicotine replacement therapy business outside the US to Dr. Reddy's Laboratories for up to 500 million pounds sterling.

10. www.marketscreener.com › quote › stockHaleon sells NRT business outside of US for GBP500 million

    www.marketscreener.com › quote › stock

    • Cached

    Jun 26, 2024 · (Alliance News) - Haleon PLC on Wednesday said it has agreed to sell its nicotine replacement therapy business outside of the US to Dr Reddy's Laboratories SA. Haleon is a Surrey, England-based consumer healthcare arm, spun out of GSK PLC.